Optimal use of off-patent medicines: the offer you cannot (afford to) refuse
Medaxes is pleased to announce that the Board of Directors has appointed Jasmien Coenen as the new Managing Director. She takes over the helm from Joris Van Assche who, to our great sadness, unexpectedly passed away on 8 August.
It is with great sadness that we inform you of the sudden decease of Joris Van Assche.
As Medaxes community, our thoughts are with his wife and children, his family and friends. We sincerely offer them our deepest sympathy.
There are no words for our disbelief and grief. Joris leaves a huge professional and personal void for us all. Not only was he our highly driven and unequalled Director, he was a warm-hearted man with the right values, a mediator and confidant for Medaxes and the whole community.
Thank you for everything, Joris. We will never forget you.
Cheap medicines in particular are at risk of falling victim to this.